跳至主要内容
临床试验/NCT01734538
NCT01734538Unknown不适用

Effects of 12 Weeks of Omega-3 Fatty Acid Supplementation on Metabolic and Physical Health Parameters in Older Adults

University of Guelph2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
2
主要终点
Change in resting heart rate from baseline

研究概览

简要总结

The biological membranes that surround a cell and its organelles are important to the overall function of the cell. Fatty acids are the main structural components of a membrane, and the presence of certain fatty acids can alter a membrane's characteristics, which subsequently alters its function. Two fatty acids that are of particular interest to researchers are eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). These omega-3 fatty acids have unique unsaturated structures, and their incorporation into biological membranes appears to elicit potent physiological effects. The body is unable to intrinsically synthesize these important fatty acids, so they must be obtained from the diet or through supplementation.

EPA and DHA supplementation has been reported to provide numerous positive health benefits, including decreased blood pressure and an improved blood lipid profile. Recent research in our laboratory has demonstrated in young men that resting metabolic rate was increased following a 12 week period of omega fatty acid supplementation of 3 g/day. Fat utilization was also increased and carbohydrate use was decreased both at rest and during a 1 hr moderate exercise challenge. These findings have positive implications for people who are interested in losing weight, but it not known whether these effects occur in older adults. With age, body composition changes (increase in fat mass and decrease in lean mass) occur which may negatively affect general health, particularly normal physical functioning and quality of living of the older adult. The potential role of omega 3 fatty acids to increase fat oxidation and increase resting metabolic rate may be a therapy for decreasing fat mass in the older adult. Research has suggested that omega 3 fatty acids may elicit an additional therapeutic role by reducing joint pain.

Another aspect of aging is a loss in lean body mass, which is associated with an attenuation of skeletal muscle protein synthesis in response to nutritional stimuli (amino acids and insulin). The weakened anabolic response is considered to be partly due to defects in the anabolic signaling cascade in the muscle. Research in older adults has reported an increase in muscle protein signaling with EPA and DHA supplementation in response to a nutritional challenge. However it is unknown whether the increase in protein signaling results in an eventual increase in lean body mass. The physical functioning of older adults is not only influenced by body composition changes, but also age-related neuronal changes that affect the velocity of axonal conduction and influence the ability of the muscle to generate torque and the rate at which the torque is developed. Muscular strength and functional capacity increases have been reported with chronic resistance exercise in a cohort of older women supplemented with EPA and DHA. However, the effect of EPA and DHA intake on physical strength in older adults with previously low EPA and DHA consumption, independent of exercise, is currently unknown.

Therefore, the purpose of this study is to determine the effects of 12 weeks of omega-3 supplementation at 3 g/day on metabolic and physical health parameters in community-dwelling older adults. We hypothesize that EPA and DHA supplementation will result in 1) a decrease in resting heart rate and blood pressure; 2) a more healthy blood profile; 3) an increase in resting metabolic rate; 4) a greater reliance on fat oxidation for energy both at rest and during exercise; and 5) a decrease in fat mass; and 6) an increase in lean mass, strength and physical function.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
60 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 60 to 74 years of age
  • Community-dwelling

排除标准

  • Current or previous supplementation with omega-3's
  • Average fish intake greater than one time per week
  • Diagnosed heart condition
  • Lightheadeness, shortness of breath, chest pain, numbness, fatigue, coughing, or wheezing during rest or at low to moderate physical activity
  • Cardiovascular disease risk factors: family history of heart attacks, hypertension, hypercholesterolemia, diabetes mellitus, and smoking
  • Allergies to lidocaine, fish/fish oil, gelatin, glycerin, or mixed tocopherols
  • Currently taking any medications or supplements that may increase the chance of bleeding (e.g. Aspirin, Coumadin, Anti-inflammatories, Plavix, Vitamin C or E, high doses of garlic, gingko biloba, willow bark products)

结局指标

主要结局

Change in resting heart rate from baseline

时间窗: baseline and 12 weeks

Change in resting blood pressure from baseline

时间窗: baseline to 12 weeks

Change in fasted blood triglyceride concentration from baseline

时间窗: baseline to 12 weeks

Change in fasted blood cholesterol from baseline

时间窗: baseline to 12 weeks

Change in blood c-reactive protein concentration from baseline

时间窗: baseline to 12 weeks

Change in fasted blood low-density lipoprotein concentration from baseline

时间窗: baseline to 12 weeks

change in fasted blood high-density lipoprotein concentration from baseline

时间窗: baseline to 12 weeks

Change in fasted blood insulin concentration from baseline

时间窗: baseline to 12 weeks

Change in fasted blood glucose concentration from baseline

时间窗: baseline to 12 weeks

Change in whole body resting fat oxidation from baseline

时间窗: baseline to 12 weeks

Change in whole body resting carbohydrate oxidation from baseline

时间窗: baseline to 12 weeks

Change in whole body sub-maximal ecercise fat oxidation from baseline

时间窗: baseline to 12 weeks

Change in whole body sub-maximal ecercise carbohydrate oxidation from baseline

时间窗: baseline to 12 weeks

Change in resting metabolic rate from baseline

时间窗: baseline to 12 weeks

Change in fat mass from baseline

时间窗: baseline to 12 weeks

Change in lean mass from baseline

时间窗: baseline to 12 weeks

Change in strength from baseline

时间窗: baseline to 12 weeks

Change in physical function (balance) from baseline

时间窗: baseline to 12 weeks

次要结局

  • Change in self-reported pain from baseline(baseline to 12 weeks)
  • Change in self-reported overall health from baseline(baseline to 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lawrence Spriet

Dr. Lawrence Spriet

University of Guelph

研究点 (2)

Loading locations...

相似试验

Effect of 12 wk of Omega-3 FA Supplementation on... | 临床试验